Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)
Technical Analysis Report for USA stock NTLA Intellia Therapeutics. Dated: 03 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics
Intellia Therapeutics Opened at 14.79 and Closed at: 13.61, which is -13.45% of previous session's close. It moved within a range of 13.60 and 14.79
The session was a Bearish session with an average volume of 8311400, which is -73.76% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 5 days back on short term averages
Support for tomorrow is 13.01 and resistance for tomorrow is 14.2
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 13.21, 12.81 resistance for tomorrow's hourly charts is 14.4, 15.19
10 Day SMA for Intellia Therapeutics (NTLA) is 13.54 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Intellia Therapeutics (NTLA) is 12.76 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Intellia Therapeutics (NTLA) is 12.03 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 12.83 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Intellia Therapeutics is 12.29 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Intellia Therapeutics is at 12.76 and 200 DMA is at 12.29, while 50 DMA and 100 DMA are at 12.03 and 12.83 respectively
Intellia Therapeutics (NTLA) moving average of 20 SMA is at 12.76 and 20 EMA is at 13.18
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Tue Mar | 13.61 | 12.76 | 13.18 |
| 02 Mon Mar | 15.44 | 12.73 | 13.13 |
| 27 Fri Feb | 13.78 | 12.61 | 12.89 |
| 26 Thu Feb | 14.29 | 12.58 | 12.8 |
| 25 Wed Feb | 13.42 | 12.56 | 12.64 |
| 24 Tue Feb | 13.58 | 12.58 | 12.56 |
Intellia Therapeutics (NTLA) moving average of 50 SMA is at 12.03 and 50 EMA is at 12.51
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Tue Mar | 13.61 | 12.03 | 12.51 |
| 02 Mon Mar | 15.44 | 11.94 | 12.47 |
| 27 Fri Feb | 13.78 | 11.81 | 12.35 |
| 26 Thu Feb | 14.29 | 11.71 | 12.29 |
| 25 Wed Feb | 13.42 | 11.61 | 12.21 |
| 24 Tue Feb | 13.58 | 11.52 | 12.16 |
Intellia Therapeutics (NTLA) moving average of 100 SMA is at 12.83 and 100 EMA is at 12.4
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Tue Mar | 13.61 | 12.83 | 12.4 |
| 02 Mon Mar | 15.44 | 12.94 | 12.38 |
| 27 Fri Feb | 13.78 | 12.99 | 12.32 |
| 26 Thu Feb | 14.29 | 13.06 | 12.29 |
| 25 Wed Feb | 13.42 | 13.12 | 12.25 |
| 24 Tue Feb | 13.58 | 13.19 | 12.23 |
Intellia Therapeutics (NTLA) moving average of 200 SMA is at 12.29 and 200 EMA is at 12.67
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Tue Mar | 13.61 | 12.29 | 12.67 |
| 02 Mon Mar | 15.44 | 12.26 | 12.66 |
| 27 Fri Feb | 13.78 | 12.22 | 12.63 |
| 26 Thu Feb | 14.29 | 12.2 | 12.62 |
| 25 Wed Feb | 13.42 | 12.17 | 12.6 |
| 24 Tue Feb | 13.58 | 12.14 | 12.59 |
Intellia Therapeutics has performed better than Takeda Pharmaceutical in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Smith Nephew in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Hca Healthcare in short term. Holding Intellia Therapeutics could be a better choice for now!
Encompass Health has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Encompass Health, about 2.8% more returns!
Community Health has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Community Health, about 1.18% more returns!
Intellia Therapeutics has performed better than Bristol Myers in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Vanda Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Trinity Biotech in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Savara Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Radnet Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Pulse Biosciences has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Pulse Biosciences, about 8.69% more returns!
Intellia Therapeutics has performed better than Omeros Corporation in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Iridex Corporation in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Immutep in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Hutchison China in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Cue Biopharma in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Axsome Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Argenx Se in short term. Holding Intellia Therapeutics could be a better choice for now!
Align Technology has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Align Technology, about 3.12% more returns!
Intellia Therapeutics Technical analysis of indicators
Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term and the buy signal is strong.
Intellia Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.11 and Intellia Therapeutics NTLA stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NTLA Experts View which covers a lot of information including buying and selling signals
NTLA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


